Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2019 | 01-2019 | 10-2018 | 07-2018 | 04-2018 | |
| Sales | 55 | 80 | 109 | 71 | 300 |
| Cost of Goods | 82 | 102 | 71 | -17 | 216 |
| Gross Profit | -28 | -22 | 37 | 88 | 84 |
| Operating Expenses | 74 | 16 | 33 | 20 | 176 |
| Operating Income | -101 | -38 | 4 | 69 | -92 |
| Interest Expense | 0 | 0 | -1 | 0 | 5 |
| Other Income | 0 | 1 | 5 | -4 | -2 |
| Pre-tax Income | -101 | -38 | 10 | 64 | -99 |
| Net Income Continuous | -101 | -38 | 9 | 64 | -99 |
| Net Income Discontinuous | 0 | 0 | 1 | 143 | N/A |
| Net Income | $-101 | $-38 | $10 | $207 | $-99 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| EBITDA(a) | $-101 | $-37 | $9 | $64 | $-85 |